Menopause

Nonhormonal Options Available for Menopause Symptom Relief

Nonhormonal Options Available for Menopause Symptom Relief

By

A nonhormonal treatment option for the relief of symptoms associated with menopause is now available alongside other drug-free supplements.

Hormone Therapy After Menopause Onset Reduces Stroke Risk

Hormone Therapy After Menopause Onset Reduces Stroke Risk

By

The use of hormone therapy up to 5 years after onset of menopause is associated with a lower risk for ischemic and hemorrhagic stroke compared with late hormone therapy initiation or no hormone therapy use.

USPSTF's Final Recommendation on Menopausal HT for Chronic Disease Prevention

USPSTF's Final Recommendation on Menopausal HT for Chronic Disease Prevention

By

To update its 2012 recommendation, the US Preventive Services Task Force reviewed evidence on the benefits and harms of systemic hormone therapy for the prevention of chronic conditions in postmenopausal women.

Accuracy of BMI as a Measurement of Obesity in Postmenopausal Women

Accuracy of BMI as a Measurement of Obesity in Postmenopausal Women

By

Findings indicate that using a BMI cutpoint of 30 may lead to bias in measuring the effects of obesity on health outcomes in postmenopausal women.

Estradiol Therapy May Benefit Overall Cognition in Postmenopausal Women

Estradiol Therapy May Benefit Overall Cognition in Postmenopausal Women

By

There may be other roles of estradiol therapy besides relief from menopause-related symptoms, including limiting effects of stress on working memory.

Early Menopause: A Greater Risk for Underweight Women

Early Menopause: A Greater Risk for Underweight Women

By

Underweight women have a significantly greater risk of experiencing early menopause compared with lean or overweight women.

Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death

Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death

By

Increased mortality risks were limited to the first post-HT year because increases in risks markedly decreased when the follow-up time was extended over more than 1 year.

Menopausal Hormone Therapy and Risk of All-Cause Mortality

Menopausal Hormone Therapy and Risk of All-Cause Mortality

By

No other randomized clinical trial of hormone therapy has been large enough to assess a potential modifying effect of age on all-cause mortality, and most previous trials of chronic disease outcomes have focused on older women.

Compounded Bioidentical Hormone Therapy in Menopause: Clinician Caution Advised

Compounded Bioidentical Hormone Therapy in Menopause: Clinician Caution Advised

Rates of cBHT prescriptions are not yet being systemically tracked, and few data exist to demonstrate the safety, efficacy, or utility of the treatment.

Managing Menopausal Symptoms in Breast Cancer Survivors

Managing Menopausal Symptoms in Breast Cancer Survivors

By

Lifestyle modification and an individualized treatment approach are effective strategies for managing menopausal symptoms in breast cancer survivors who are largely advised to avoid hormone replacement therapy.

Does Transdermal Estrogen Improve Sexual Function in Early Postmenopause?

Does Transdermal Estrogen Improve Sexual Function in Early Postmenopause?

By

The Female Sexual Functioning Index was used to assess aspects of sexual function and experience in early postmenopausal women.

K-Postn Assay New Tool to Assess Fracture Risk in Postmenopausal Women

K-Postn Assay New Tool to Assess Fracture Risk in Postmenopausal Women

By

According to a study published in the Journal of Bone and Mineral Research, researchers hypothesized that serum K-Postn levels may be able to predict low-trauma fractures.

FDA Approves Treatment for Menopause Associated Dyspareunia

FDA Approves Treatment for Menopause Associated Dyspareunia

By

Intrarosa, the first FDA approved local, non-estrogen product for treating dyspareunia, is now available.

AACE/ACE Updated Position Statement on Menopause

AACE/ACE Updated Position Statement on Menopause

By

Although the updated statement does not change the recommendations outlined in previous treatment guidelines, the authors have added 8 new recommendations based on evidence that has emerged in the interim.

Estrogen Exposure and Depression Risk Examined

Estrogen Exposure and Depression Risk Examined

A combination of early menstruation with more frequent periods may lower a woman's depression risk.

Increased RA Risk in Post-Menopause, Early Post-Menopause

Increased RA Risk in Post-Menopause, Early Post-Menopause

By

Acute decline in ovarian function may contribute to the autoimmunity associated with rheumatoid arthritis.

North American Menopause Society Releases New Guidelines for Hormone Therapy

North American Menopause Society Releases New Guidelines for Hormone Therapy

The North American Menopause Society released updated guidelines for hormone therapy use in women who are postmenopausal.

Fracture Risk Decreases, Bone Mineral Density Increases With Long-Term Denosumab

Fracture Risk Decreases, Bone Mineral Density Increases With Long-Term Denosumab

By

Long-term denosumab increased bone mineral density in postmenopausal women.

Frequent Hot Flashes Worsened Endothelial Function in Younger Midlife Women

Frequent Hot Flashes Worsened Endothelial Function in Younger Midlife Women

By

Age significantly affected the association between hot flash status and flow-mediated dilation, particularly in younger women.

Fewer Menstrual Cycles May Lead to Increased Risk for Heart Failure

Fewer Menstrual Cycles May Lead to Increased Risk for Heart Failure

By

The fewer menstrual cycles women had over a lifetime placed them at greater risk for incident heart failure.

Oral HRT Increases Postmenopausal Hearing Loss Risk

Oral HRT Increases Postmenopausal Hearing Loss Risk

Research results indicate that more randomized clinical trials are needed to examine the relationship between hearing loss and oral hormone replacement therapy.

Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopausal Women

Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopausal Women

By

After 24 months, bone mineral density was statistically different from baseline.

Decline in Lung Function Linked to Menopausal Status

Decline in Lung Function Linked to Menopausal Status

Serum samples, spirometry, and questionnaire data were collected from nearly 1500 women to determine if menopausal status affected lung function.

Is Normal Basal Bone Metabolism Vitamin D-Dependent in Postmenopausal Women With T2D?

Is Normal Basal Bone Metabolism Vitamin D-Dependent in Postmenopausal Women With T2D?

Findings in postmenopausal women with T2DM; correlations prominent in those with higher 25(OH)D

Intravisceral Abdominal Fat Mass Reduction With Menopausal Hormone Therapy

Intravisceral Abdominal Fat Mass Reduction With Menopausal Hormone Therapy

By

Researchers examined body mass index differences in current, past, and never users of menopausal hormone therapy.

Decreased Mortality, CAC Scores With Hormone Replacement Therapy

Decreased Mortality, CAC Scores With Hormone Replacement Therapy

By

HRT in postmenopausal women was linked to lower CAC scores and a lower risk of long-term, all-cause mortality.

Postmenopausal Anxiety Linked to Severe Quality of Life Impairment

Postmenopausal Anxiety Linked to Severe Quality of Life Impairment

By

Severe anxiety was independently associated with poor quality of life in postmenopausal patients.

Early Menopause Tied to Rheumatoid Arthritis Risk

Early Menopause Tied to Rheumatoid Arthritis Risk

By

Data from the Nurses' Health Studies were analyzed to determine if there is a link between seropositive and seronegative rheumatoid arthritis and age of menopause onset.

Menopause Predicted by Anti-Müllerian Hormone in HIV

Menopause Predicted by Anti-Müllerian Hormone in HIV

For women with HIV, anti-Müllerian hormone is associated with age of menopause onset.

Aging vs Menopausal Status as a Predictor of Depression, Negative Mood

Aging vs Menopausal Status as a Predictor of Depression, Negative Mood

By

Women in the menopausal transition and early postmenopause are at higher risk for depressive symptoms and negative mood than those in late postmenopause.

Sign Up for Free e-Newsletters

CME Focus